Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt

This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists.

Saved in:
Bibliographic Details
Main Authors THOMPSON, DAVID DUANE, PARALKAR, VISHWAS MADHAV
Format Patent
LanguageDanish
Published 28.08.2006
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists.
AbstractList This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists.
Author PARALKAR, VISHWAS MADHAV
THOMPSON, DAVID DUANE
Author_xml – fullname: THOMPSON, DAVID DUANE
– fullname: PARALKAR, VISHWAS MADHAV
BookMark eNqNjb0KwjAURjvo4N87XLd2EOwP4ipaFVw6dC-xvY0h4SYk14Jvbws-gNNZzvm-ZTQjS7iIwokGpA5NQBA9OG8DC2kEdYogrm5llkBAg5rVgOCxRcfWQwFxWRUJCGlJBUYPrAw88TWGRpGctoR-M1gJ2k-OBvp4DIOSvI7mvRgPNz-uou21rM_3HTrbYHCiRUJuLo80zbP98VDXef6P8wWT1ETQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DK1132086TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_DK1132086TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Danish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DK1132086TT33
Notes Application Number: DK20010300690T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060828&DB=EPODOC&CC=DK&NR=1132086T3
ParticipantIDs epo_espacenet_DK1132086TT3
PublicationCentury 2000
PublicationDate 20060828
PublicationDateYYYYMMDD 2006-08-28
PublicationDate_xml – month: 08
  year: 2006
  text: 20060828
  day: 28
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies PFIZER PRODUCTS INC
RelatedCompanies_xml – name: PFIZER PRODUCTS INC
Score 2.647109
Snippet This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060828&DB=EPODOC&locale=&CC=DK&NR=1132086T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEG4QjfqmqEH8kZqYBR4WGSsMHhYj25BIgMVMwxtp6SDLzLawofG_924C-qJvzZpctjZ316-77ztCbv1ZU_qMa6qQhlSZlJraBpyhCqPekVyHBNJAcvJw1Oq_sKdJc1IgwYYLk-uEfuTiiOBRM_D3LI_Xyc8llp3XVqZ3IoBH8X3PM21li45RkU2xu6bjju2xpViWaQ-U0bOJDdXh9O7pO2QXT9Eos--8dpGUkvzOKL0jsueCsSg7JgXJS-TA2jReK5H94fp_NwzXrpeekPQBy8MlpjLK5zRBtgbPG3AEEa26j06jRrFzUojxi0Ic8xOA05TRquOyGuWLGDVy_SXNgjeK5PxIIhMdbfFwldF4QUPUyU1DGn0CBn8PFtkpuek5ntVX4e2n25Wa2oPNd3q6fkaKURz5ZUJFs8UMgKJzJgzW5vWOr82MuWgYQmiwWa1zUvnbTuW_yQty-H0nAe7WviTFbLnyryBLZ-I6X98v47OYKg
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT8JAEJ0gGvGmqFH8WhPTwKGR0oXCoTHSFlG-GlMNN9JlC2lq2oYWjf_enQroRW-bbjJpdzMz-7bz3gDceNM696iryIxrXKacK3JT4AyZadUWd1WRQGpITh4MG90X-jSuj3Pgr7kwmU7oRyaOKDxqKvw9zeJ1_HOJZWa1lckt88Wj6K7j6Ka0QceoyCaZbd2yR-bIkAxDN3vS8FnHhuri9O6oW7CtoTgvnpxe20hKiX9nlM4-7NjCWJgeQI67RSgY68ZrRdgdrP53i-HK9ZJDSO6xPJxjKiPujMTI1nCzBhx-SMr2g1WrEOycFGD8IiKOebGA04SSsmXTCnHnEWrkeguS-m8EyfkhRyY62nKDZUqiOQlQJzcJSPgpMPi7P0-P4LpjOUZXFm8_2azUxOytv9NR1WPIh1HonQBh9QbVBBSdUabRplttecpUm7GaxpgiNqtxCqW_7ZT-m7yCQtcZ9Cf9x2HvDPa-7yeE6zXPIZ8ult6FyNgpu8zW-gsq4JsX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Anvendelse+af+prostaglandin+%28PGE2%29+selektive+receptor+4+%28EP4%29+agonister+til+behandling+af+akut+og+kronisk+nyresvigt&rft.inventor=THOMPSON%2C+DAVID+DUANE&rft.inventor=PARALKAR%2C+VISHWAS+MADHAV&rft.date=2006-08-28&rft.externalDBID=T3&rft.externalDocID=DK1132086TT3